AUNA PROVIDES UPDATE ON CAPITAL STRUCTURE INITIATIVES
LUXEMBOURG CITY, Luxembourg, Oct. 25, 2023 /PRNewswire/ -- Auna S.A. ("Auna" or the "Company") intends to confidentially submit a draft registration statement on Form F-1 to the U.S. Securities and Exchange Commission (the "SEC") for a proposed initial public offering of Auna's Class A shares in the U.S. The Company is contemplating consummating the proposed initial public offering sometime in 2024, but both the offering itself and the timing thereof are subject to market conditions, other considerations, and the completion of the SEC's review process.
The underlying decision to raise equity capital in the international capital markets is a part of Auna's broader strategy to strengthen its capital base, extend its debt maturities and continue its expansion in Spanish Speaking Latin America.
This press release is not an offer to sell, or the solicitation of an offer to buy, any securities. Any offers, solicitations or offers to buy, or any sales of securities will be made in accordance with the registration requirements of the U.S. Securities Act of 1933 and other applicable securities laws.
In response to valuable feedback from our customers, Luraco Technologies is thrilled to announce the launch of an upgrade to our medical massage chair lineup. We are introducing the Luraco i9 Max Plus Series, a revolution of the i9 Max Series. The i9...
Proteologix, Inc., a privately-held biotechnology company focused on bispecific antibodies for immune-mediated diseases, today announced that it has entered into a definitive agreement to be acquired by Johnson & Johnson for $850 million in cash,...
Seelos Therapeutics, Inc. ("Seelos" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system ("CNS") disorders and rare diseases, announced today that it has entered into a...
We are advised by Hidden River Eating Disorder Residential Treatment that journalists and other readers should disregard the news release, Hidden River Announces Insurance Contract with Blue Cross Blue Shield, issued 16-May-2024 over PR Newswire....
Full-Life Technologies (Full-Life), a fully integrated global radiotherapeutics company, today announced the appointment of Mark S. de Jong, PhD, to the newly created position of Chief Technical Officer (CTO). Dr. de Jong, joins Full-Life with 43...
